These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9148747)

  • 1. Reduced beta-strand content in apoprotein B-100 in smaller and denser low-density lipoprotein subclasses as probed by Fourier-transform infrared spectroscopy.
    Tanfani F; Galeazzi T; Curatola G; Bertoli E; Ferretti G
    Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):765-9. PubMed ID: 9148747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary structure of the particle associating domain of apolipoprotein B-100 in low-density lipoprotein by attenuated total reflection infrared spectroscopy.
    Goormaghtigh E; Cabiaux V; De Meutter J; Rosseneu M; Ruysschaert JM
    Biochemistry; 1993 Jun; 32(23):6104-10. PubMed ID: 8507644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and orientation of apo B-100 peptides into a lipid bilayer.
    Lins L; Brasseur R; Rosseneu M; Yang CY; Sparrow DA; Sparrow JT; Gotto AM; Ruysschaert JM
    J Protein Chem; 1994 Jan; 13(1):77-88. PubMed ID: 8011074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the secondary structure of apolipoprotein B-100 after Cu2+-catalysed oxidation of human low-density lipoproteins monitored by Fourier transform infrared spectroscopy.
    Herzyk E; Lee DC; Dunn RC; Bruckdorfer KR; Chapman D
    Biochim Biophys Acta; 1987 Nov; 922(2):145-54. PubMed ID: 3676339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction.
    Lund-Katz S; Laplaud PM; Phillips MC; Chapman MJ
    Biochemistry; 1998 Sep; 37(37):12867-74. PubMed ID: 9737865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the secondary structure of apo B-100 in low-density lipoprotein (LDL) by infrared spectroscopy.
    Goormaghtigh E; De Meutter J; Vanloo B; Brasseur R; Rosseneu M; Ruysschaert JM
    Biochim Biophys Acta; 1989 Nov; 1006(1):147-50. PubMed ID: 2804067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men.
    Krauss RM; Dreon DM
    Am J Clin Nutr; 1995 Aug; 62(2):478S-487S. PubMed ID: 7625363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FT-IR spectroscopy of lipoproteins--a comparative study.
    Krilov D; Balarin M; Kosović M; Gamulin O; Brnjas-Kraljević J
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Aug; 73(4):701-6. PubMed ID: 19414281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the structure of apolipoprotein B-100 determine the behaviour of LDL towards thromboplastin.
    Ettelaie C; Haris PI; James NJ; Wilbourn B; Adam JM; Bruckdorfer KR
    Biochim Biophys Acta; 1997 Apr; 1345(3):237-47. PubMed ID: 9150244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization and preliminary X-ray diffraction data of two different human low-density lipoprotein (LDL) subfractions.
    Ritter S; Frey I; Diederichs K; Grathwohl D; Keul J; Baumstark MW
    Proteins; 1997 Jun; 28(2):293-7. PubMed ID: 9188746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of kinetic inhibition of Cu(II)-induced oxidation of low density lipoprotein by lanthanide ions.
    Liu H; Cheng Y; Lu J; Li R; Wang K
    J Inorg Biochem; 2006 Jul; 100(7):1280-9. PubMed ID: 16678267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content.
    Benítez S; Villegas V; Bancells C; Jorba O; González-Sastre F; Ordóñez-Llanos J; Sánchez-Quesada JL
    Biochemistry; 2004 Dec; 43(50):15863-72. PubMed ID: 15595841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits.
    Rizzo M; Taylor JM; Barbagallo CM; Berneis K; Blanche PJ; Krauss RM
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):141-6. PubMed ID: 14615390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-core relationships in human low density lipoprotein as studied by infrared spectroscopy.
    Bañuelos S; Arrondo JL; Goñi FM; Pifat G
    J Biol Chem; 1995 Apr; 270(16):9192-6. PubMed ID: 7721835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One site on the apoB-100 specifically binds 17-beta-estradiol and regulates the overall structure of LDL.
    Brunelli R; Greco G; Barteri M; Krasnowska EK; Mei G; Natella F; Pala A; Rotella S; Ursini F; Zichella L; Parasassi T
    FASEB J; 2003 Nov; 17(14):2127-9. PubMed ID: 14500554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.